Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JAC/DKH048PMID 14711840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

  2003cited by this paper
• Variability of treatment duration for bacteraemia in the critically ill: a multinational survey.

  2003cited by this paper
• Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.

  2003cited by this paper
• Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.

  2003cited by this paper
• Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.

  2002cited by this paper
• Hematologic Effects of Antimicrobials: Focus on the Oxazolidinone Linezolid

  2001cited by this paper
• Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

  2001cited by this paper
• Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

  2001cited by this paper
• Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.

  2001cited by this paper
• Breast Cancer Research and Treatment

  2001cited by this paper
• MRSA in the critically ill.

  2001cited by this paper
• Linezolid: a review of its use in the management of serious gram-positive infections.

  2001cited by this paper
• Increasing threat of Gram-positive bacterial infections in the intensive care unit setting

  2001cited by this paper
• Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections

  2000cited by this paper
• Epidemiology of antibiotic resistance

  2000cited by this paper
• Trends in antimicrobial-drug resistance in Japan.

  2000cited by this paper
• Clinical Pharmacokinetics of Teicoplanin

  2000cited by this paper
• Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

  2000cited by this paper
• National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System.

  1999cited by this paper
• In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant Enterococci

  1999cited by this paper
• [Cost analysis concerning MRSA-infection in ICU].

  1999cited by this paper
• Eine Kostenanalyse von MRSA-Infektionen auf einer operativen Intensivstation

  1999cited by this paper
• Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci.

  1999cited by this paper
• Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA.

  1998cited by this paper
• Analysis of longitudinal data

  1998cited by this paper
• Decreased Susceptibilities to Teicoplanin and Vancomycin among Coagulase-Negative Methicillin-Resistant Clinical Isolates of Staphylococci

  1998cited by this paper
• Has the mortality of septic shock changed with time.

  1998cited by this paper
• Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

  1997cited by this paper
• Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients.

  1996cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996cited by this paper
• The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

  1995cited by this paper
• Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.

  1995cited by this paper
• Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

  1995cited by this paper
• Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units

  1995cited by this paper
• Intensive Care Society's Acute Physiology and Chronic Health Evaluation (APACHE II) study in Britain and Ireland: A prospective, multicenter, cohort study comparing two methods for predicting outcome for adult intensive care patients

  1994cited by this paper
• Intermediate TISS: A new Therapeutic Intervention Scoring System for non‐ICU patients

  1994cited by this paper
• Nosocomial Infections Surveillance

  1993cited by this paper
• Guidelines for the use of innovative therapies in sepsis.

  1993cited by this paper
• Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.

  1993cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Efficacy of antibiotic prophylaxis.

  1989cited by this paper
• Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

  1986cited by this paper
• Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital.

  1980cited by this paper
• A semiquantitative culture method for identifying intravenous-catheter-related infection.

  1977cited by this paper

• Therapeutic approaches for septicemia induced by multidrug-resistant bacteria using desert-adapted plants

  2025influential citation
• Population Pharmacokinetics of Linezolid in Patients with Severe Infection

  2025cites this paper
• Population Pharmacokinetic/Pharmacodynamic Study of Linezolid in Hospital-Acquired Pneumonia Patients with Renal Insufficiency

  2024cites this paper
• Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice

  2024cites this paper
• Clinical significance of polyunsaturated fatty acids in the prevention of cardiovascular diseases

  2022cites this paper
• Mortality and clinical cure rates for pneumonia: A systematic review, meta-analysis, and trial sequential analysis of randomized control trials comparing bactericidal and bacteriostatic antibiotic treatments.

  2022cites this paper
• Role of linezolid combination therapy for serious infections: review of the current evidence

  2020cites this paper
• In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters

  2020cites this paper
• Comparative Evaluation of Linezolid and Teicoplanin in the Treatment of Ventilator-Associated MRSA Pneumonia: A Single-Center Experience

  2020influential citation
• Developing an isotope dilution UHPLC-MS/MS method to quantify linezolid in human plasma: application to therapeutic drug monitoring.

  2020cites this paper
• Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.

  2020cites this paper
• Clinical outcomes of teicoplanin use in the OPAT setting

  2020cites this paper
• Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition

  2019cites this paper
• Antimicrobial treatment of nosocomial meticillin-resistant (MRSA) pneumonia: current and future options

  2019cites this paper
• Effect of vancomycin, teicoplanin, and linezolid on renal function of critically ill patients with sepsis

  2019cites this paper
• Risk factors associated with MRSA

  2018cites this paper
• Efficacy and safety of linezolid versus teicoplanin for the treatment of MRSA infections: a meta-analysis.

  2018cites this paper
• Linezolid: a review of its properties, function, and use in critical care

  2018cites this paper
• Isolation of methicillin-resistant Staphylococcus aureus from burn centers and evaluation of antimicrobial efficacy, in Faisalabad, Pakistan

  2018cites this paper
• Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.

  2017cites this paper
• Evaluation of the Clinical Course of Methicillin-resistant Staphylococcus Aureus Infections in Consideration of the Efficacy of Linezolid

  2017cites this paper
• Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of MRSA infection: a health-care system perspective

  2017influential citation
• Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

  2016cites this paper
• MRSA: treating people with infection.

  2016cites this paper
• Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.

  2016cites this paper
• Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia.

  2016cites this paper
• Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review

  2016cites this paper
• Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis.

  2016cites this paper
• Consensus statement on the management of methicillin‐resistant Staphylococcus aureus nosocomial pneumonia in Asia

  2015cites this paper
• Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.

  2015cites this paper
• Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model

  2015cites this paper
• A Review of Teicoplanin Used in the Prevention and Treatment of Serious Infections Caused by Gram-Positive Bacteria and Compared Its Effects with Some other Antibiotics

  2015cites this paper
• Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study

  2014influential citation
• Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis

  2014cites this paper
• Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials

  2013cites this paper
• Quantification of linezolid in serum by LC-MS/MS using semi-automated sample preparation and isotope dilution internal standardization

  2013cites this paper
• The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections

  2013cites this paper
• Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus

  2013cites this paper
• The Role of Ica Operon and Biofilm Formation in Coagulase Negative Staphylococcal Infection

  2012cites this paper
• Methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

  2012cites this paper
• [Daptomycin therapy in patients with bacteremia].

  2012cites this paper
• Soft tissue and bone MRSA infections.

  2011cites this paper
• Efficacy and safety of linezolid in liver transplant patients

  2011cites this paper
• Effect of systemic antibiotics and topical chlorhexidine on meticillin-resistant Staphylococcus aureus carriage in intensive care unit patients.

  2011cites this paper
• Modelo de probabilidad para predecir una neumonía nosocomial por Staphylococcus aureus resistente a meticilina

  2011cites this paper
• Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.

  2011cites this paper
• Nosocomial MRSA pneumonia: data from recent clinical trials.

  2011cites this paper
• Controlled Trials Pneumonia : A Meta-analysis of Randomized Nosocomial Staphylococcus aureus Methicillin-Resistant Treatment of Suspected Linezolid vs Glycopeptide Antibiotics for the

  2011cites this paper
• Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.

  2011cites this paper
• Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditis.

  2010cites this paper
• Consensus document on controversial issues for the treatment of hospital-associated pneumonia.

  2010cites this paper
• Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*

  2010cites this paper
• Prosthetic joint infections: single versus combination therapy.

  2010cites this paper
• The diagnosis and management of prosthetic joint infections.

  2010cites this paper
• [Guidelines for prevention, control and treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA): changes and updates of chapter 7.0: treatment of patients with MRSA infection].

  2010cites this paper
• A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

  2010cites this paper
• Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.

  2010cites this paper
• [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].

  2010cites this paper
• Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.

  2010cites this paper
• MRSA: treating people with infection.

  2010cites this paper
• [Linezolid in the treatment of gram positive coccal infections in critical patients].

  2010cites this paper
• Originales Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections

  2010cites this paper
• Present and Emerging Therapies for the Treatment of Drug-resistant Infections: Focus on Linezolid

  2010cites this paper
• Clinical Experience with Linezolid at a Large Academic Medical Center: A Case Series and Review of the Literature

  2010cites this paper
• Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.

  2010cites this paper
• Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections

  2010cites this paper
• Antibiotic Resistance of Non-Pneumococcal Streptococci and Its Clinical Impact

  2009cites this paper
• Synthesis and antimicrobial activity of new tetrahydro‐naphthalene‐thiazolidinedione and thiohydantoine derivatives

  2009cites this paper
• Use of linezolid in critically ill patients admitted to intensive care units.

  2009cites this paper
• The Role of MRSA in Healthcare-Associated Pneumonia

  2009cites this paper
• Linezolid: a review of safety and tolerability.

  2009cites this paper
• Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany

  2009cites this paper
• In Vitro and In Vivo Efficacies of Teicoplanin-Loaded Calcium Sulfate for Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis

  2009cites this paper
• Development and characterization of a transdermal patch and an emulgel containing kanamycin intended to be used in the treatment of mycetoma caused by Actinomadura madurae

  2009cites this paper
• Future gazing in the management of multiply drug-resistant Gram-positive infection.

  2009cites this paper
• Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.

  2008cites this paper
• The evaluation and treatment of complicated skin and skin structure infections

  2008cites this paper
• [Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].

  2008cites this paper
• Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials.

  2008cites this paper
• Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.

  2008cites this paper
• Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study.

  2008cites this paper
• Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials

  2008cites this paper
• [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].

  2008cites this paper
• AN UPDATE ON THE MANAGEMENT OF HOSPITAL-ACQUIRED PNEUMONIA IN THE ELDERLY

  2008cites this paper
• Guía de tratamiento de la infección producida por Staphylococcus aureus resistente a meticilina

  2008cites this paper
• Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy

  2008cites this paper
• Linezolid for the treatment of skin and soft-tissue infections

  2008cites this paper
• Evaluation of Linezolid for Patients with MRSA Infection in Showa University Fujigaoka Hospital

  2008cites this paper
• Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

  2008cites this paper
• Lack of increase in time to blood culture positivity in a patient with persistent methicillin-resistant Staphylococcus aureus bacteremia predicts failure of antimicrobial therapy.

  2008cites this paper
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cites this paper
• Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials.

  2008cites this paper
• DESARROLLO DE UN MODELO DE PROBABILIDAD PARA PREDECIR LA NEUMONÍA NOSOCOMIAL POR STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA

  2007cites this paper
• [Summary of the GEIPC-SEIMC and GTEI-SEMICYUC recommendations for the treatment of infections caused by gram positive cocci in critical patients].

  2007cites this paper
• [GEIPC-SEIMC and GTEI-SEMICYUC recommendations for antibiotic treatment of gram positive coccal infections in the critical patient].

  2007cites this paper
• Recomendaciones GEIPC-SEIMC y GTEI-SEMICYUC para el tratamiento antibiótico de infecciones por cocos grampositivos en el paciente crítico

  2007cites this paper
• An infectious disease update on antibiotics: emerging resistance.

  2007cites this paper
• Linezolid: effectiveness and safety for approved and off-label indications

  2007influential citation
• Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance.

  2007influential citation
• Linezolidが奏効した小児methicillin-resistant Staphylococcus aureus (MRSA) 敗血症の1例

  2007cites this paper